Beaver
glaucoma_net_ru
cophyeu
oftalmolog_club
www.worldglaucoma.org
Mobile
icglaucoma.org
nidek
eye5
Конгресс 2014
icgs2018
cophyaa
medlab
Ассоциации
Первая пятница декабря
ВК
АйНьюс.РФ
Флаги
Торика
Основные мероприятия ассоциации офтальмологов
Конгресс
askin_heid
camopht
Шахматы
varthamana2
bannerparasol
facebook
профессор
appstore
YouTube
конгресс 2018
santen
Главная / Новости

Новости


1 2 3 4 5 6 7 8 9 10


21 июля 2018 - Fighting Glaucoma: An Action Handbook
The long term challenges faced by people with glaucoma are numerous and important. With such a diagnosis, you have to balance many life demands, of which eye treatments are essential but by no means alone. After all, you are not living to treat glaucoma: you are living a full life into which the treatment of your condition is an intrusion

19 июля 2018 - Heidelberg Engineering prepares leadership team for the future
Heidelberg, Germany – Heidelberg Engineering GmbH announced today changes to the leadership team responsible to consistently deliver the company’s brand promise of excellence and innovation, supported by knowledge and confidence

14 июля 2018 - Advances in Filtering Surgery
his prospective, noncomparative, multicenter study was designed to evaluate the safety and efficacy of an ab interno gelatin stent (Xen Gel Stent, Allergan). Sixty-five patients aged 45 years or older with refractory open-angle glaucoma (OAG) and a history of failed filtering or cilioablative surgery and/or uncontrolled IOP (≥ 20 and ≤ 35 mm Hg) on maximum tolerated medical therapy were enrolled. The study protocol required a conjunctival peritomy to allow direct sponge application of 0.2 mg/mL mitomycin C (MMC) to the scleral bed for 2 minutes. The gelatin stent was then implanted in the sub-Tenon space in an ab interno fashion via a clear corneal incision under gonioscopic guidance, after which the conjunctiva was closed

13 июля 2018 - Icare® rebound tonometers: review of their characteristics and ease of use
Abstract: The rebound tonometer has a unique mechanism for measuring intraocular pressure (IOP) and has become popular worldwide due to its ease of use. The most notable advantages are the lack of an air-puff and need for topical anesthesia, ease of operation and transport, and the ability to use it with children. Four rebound tonometers (Icare® TA01i, Icare PRO, Icare HOME, and Icare ic100) are currently available for clinical examination. It is important to understand the characteristics of each tonometer and select the most appropriate one because the IOP values and the purpose of measurement are different. In this review, with the goal of improving the understanding of a range of tonometers, the issues with each device are discussed.

10 июля 2018 - Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma
Abstract Purpose: Rho-associated protein kinase (ROCK) inhibitors lower intraocular pressure (IOP) by increasing aqueous outflow through the trabecular meshwork (TM). The preclinical characterization of netarsudil, a new ROCK/norepinephrine transporter (NET) inhibitor currently in clinical development, is presented herein.

09 июля 2018 - Would you like to actively participate in the World Glaucoma Congress in Melbourne?
This is your chance to submit your abstract and have it reviewed within 2 weeks after submission. A new concept to be introduced at WGC-2019: Express Abstract Review.

05 июля 2018 - Big data and glaucoma
The WGA aspires in becoming the most important source of education for ophthalmologists and other healthcare providers related to glaucoma. In becoming a knowledge platform, the association offers access to the Educational Portal that includes recorded sessions from past WGC’s.

03 июля 2018 - Ocular Therapeutix resubmits new drug application for Dextenza
Ocular Therapeutix has resubmitted a new drug application to the FDA for its ocular pain treatment Dextenza, the company announced in a press release. Dextenza (dexamethasone insert 0.4 mg) is a corticosteroid intracanalicular insert placed through the punctum to deliver dexamethasone for up to 30 days.

26 июня 2018 - MultiColor shines at ARVO in comparisons to color fundus photography
A number of international studies evaluating the sensitivity of SPECTRALIS® MultiColor confocal scanning laser ophthalmoscopy versus color fundus photography were presented at the Association for Vision and Research in Ophthalmology (ARVO) 2018 conference in Honolulu, Hawaii. The studies presented at ARVO reported better sensitivity and visualization of a number of pathologies using the SPECTRALIS MultiColor Module in comparison to color fundus photography. In the figure below Amit Meshi, UCSD, San Diego, California, USA, et al. compared retinal pathology visualization and detection between the three technologies: SPECTRALIS MultiColor Module (image B), Optos P200 (image C) and Topcon TRC-50DX (image A). The authors concluded that whilst overall detection rate of retinal pathology was similar across all three devices, a larger area of macular involvement and significantly better epiretinal membrane (ERM) visualization was noted in the SPECTRALIS.

23 июня 2018 - Preserving the Ocular Surface: Practice Pearls Part 3
Dry eye symptoms are experienced by many patients, especially with aging. Unfortunately, millions of patients with ocular surface disease are underdiagnosed in the United States. Being able to detect and treat dry eye disease in its early stages is becoming increasingly important. This CME activity will discuss the etiology, pathophysiology, and new methods of diagnosis and treatment for ocular surface disorders, as well as discuss clinical cases.

13 июня 2018 - Argus II retinal prosthesis system: a review of patient selection criteria, surgical considerations, and post-operative outcomes
Abstract: Retinitis pigmentosa (RP) is a group of heterogeneous inherited retinal degenerative disorders characterized by progressive rod and cone dysfunction and ensuing photoreceptor loss. Many patients suffer from legal blindness by their 40s or 50s. Artificial vision is considered once patients have lost all vision to the point of bare light perception or no light perception. The Argus II retinal prosthesis system is one such artificial vision device approved for patients with RP. This review focuses on the factors important for patient selection. Careful pre-operative screening, counseling, and management of patient expectations are critical for the successful implantation and visual rehabilitation of patients with the Argus II device.

12 июня 2018 - Are you attending WOC2018 in Barcelona? Be sure to join the WGA Symposium Glaucoma: Clinical Features and Progression on Tuesday.
Are you attending WOC2018 in Barcelona? Be sure to join the WGA Symposium Glaucoma: Clinical Features and Progression on Tuesday. We look forward to meeting you there

11 июня 2018 - Journal Article Review – Use of MultiColor imaging in the assessment of suspected papilledema in 20 consecutive children
True papilledema or pseudopapilledema? Differentiating between these entities in children based on noninvasive imaging would be greatly preferable over an invasive neurological examination – the current gold standard. The authors of a recent study investigated whether the SPECTRALIS® MultiColor Module is helpful to make this distinction. Taking MultiColor images from the optic nerve head of 20 consecutive patients delivered very promising results.

10 июня 2018 - Пора полистать "свежий" выпуск International Glaucoma Review
Dr. Robert N. Weinreb Chief Editor I welcome you to the International Glaucoma Review (IGR) online. As usual, the IGR will provide you with high quality glaucoma content including the Comments in the Editor’s Selection, the Dialogue, Opinion, and news from the WGA, meeting reports, etc. With this new format, you will be able to quickly navigate the content online and obtain the information that is of interest. If desired, you also will be able to obtain more details via direct links (articles, abstracts, database, etc.).

08 июня 2018 - A truly comprehensive Ophthalmology meeting, delivering a world class scientific programme
With plans well underway for SOE2019 we are pleased to share our confirmed Key note Lectures which cover the breadth of Ophthalmology and are just some of the jewels in our treasure chest that is our Scientific programme. We look forward to welcoming you to the next European Congress of Ophthalmology in Nice from 13–16 June 2019. Along with a selection of the best lecturers in the world who will share every conceivable aspect of ophthalmology, our YO Committee will provide specific YO activities and sessions and the most recent state-of-art equipment and devices will be on display at the exhibition. We look forward to seeing you in Nice in 2019! Jan Tjeerd de Faber SOE President

07 июня 2018 - Хотите увидеть много фото с конгресса во Флоренции?
Отличные фото с отличного конгресса Европейского глаукомного общества!

06 июня 2018 - Отличные презентации по разным темам глаукомы (представленные на Всемирном глаукомой конгрессе в 2017 году)
The WGA aspires in becoming the most important source of education for ophthalmologists and other healthcare providers related to glaucoma. In becoming a knowledge platform, the association offers access to the Educational Portal that includes recorded sessions from past WGC’s. Click below to watch the recorded sessions of our past Congresses. WGC-2013 and WGC-2015 content is available for all. The sessions recorded during the 7th WGC will only be available for registered participants and will be released on a monthly basis via the different WGA media channels. WGC-2017 content is only available to WGC-2017 attendees. WGA will share several WGC-2017 sessions the upcoming year via WGA media channels. Do not miss out and subscribe to the WGA newsletter!

30 мая 2018 - Visionary Cataract and Refractive Techniques: Explore With Us
Каких-то 165 лет? )

28 мая 2018 - Marijuana and Glaucoma. А вот так!
Many patients inquire about the use of marijuana for their uncontrolled glaucoma, especially in the setting of increased legalization in many states. In this article, Dr. Graul discusses various limitations of this Schedule I drug for long-term treatment of glaucoma, including its short duration of action, cost, ocular side effects, general health risks, and high potential for abuse. BY THOMAS A. GRAUL, MD

27 мая 2018 - Новости диагностики глаукомы!
n recent years, retinal injuries caused by laser pointers have increased significantly - especially among young people. What are the preferred imaging modalities to identify these injuries? What difficulties can be expected? What role does OCT play? In his video presentation, Ethan Priel, Director of Ophthalmology Dept., MOR Institute Israel, discusses the topic comprehensively.


1 2 3 4 5 6 7 8 9 10
Голосование
Что "заставляет" Вас заниматься научными исследованиями?